3-(tert-Butyl) 2-methyl (1R,2S,5S)-3-azabicyclo[3.1.0]hexane-2,3-dicarboxylate

Catalog No.: 
ACVTQN621
CAS No.: 
865184-03-8
Molecular Formula: 
C12H19NO4
Molecular Weight: 
241.29
3-(tert-Butyl) 2-methyl (1R,2S,5S)-3-azabicyclo[3.1.0]hexane-2,3-dicarboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$705.00InquiryInquiry
1g98%$1762.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(tert-Butyl) 2-methyl (1R,2S,5S)-3-azabicyclo[3.1.0]hexane-2,3-dicarboxylate
IUPAC Name3-(tert-butyl) 2-methyl (1R,2S,5S)-3-azabicyclo[3.1.0]hexane-2,3-dicarboxylate
Molecular FormulaC12H19NO4
Molecular Weight241.29
SMILESO=C([C@@H]1[C@]2([H])C[C@]2([H])CN1C(OC(C)(C)C)=O)OC
InChI KeyQWMJCMSVCCQJRA-HLTSFMKQSA-N
Synonym3-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic acid, 3-(1,1-dimethylethyl) 2-methyl ester, (1R,2S,5S)-;3-(tert-butyl) 2-methyl (1R,2S,5S)-3-azabicyclo[3.1.0]hexane-2,3-dicarboxylate
CAS No.865184-03-8

Synthetic Route by SureRoute

1. ACVTQN621 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWJHF723 route compound structure diagram
    ACWJHF723927679-50-3In Stock
  4. Then
  5. ACVTQN621 route product structure diagram
    ACVTQN621865184-03-8
Inquiry

2. ACVTQN621 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEMRL267 route compound structure diagram
    ACEMRL26774844-93-2In Stock
  2. Plus
  3. ACNXUH296 route compound structure diagram
    ACNXUH2961774-47-6In Stock
  4. Then
  5. ACVTQN621 route product structure diagram
    ACVTQN621865184-03-8
Inquiry

3. ACVTQN621 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVTQN621 route product structure diagram
    ACVTQN621865184-03-8
Inquiry

Comments (0)